The market is showcasing evident potential in the mentioned forecasting period. MAb`s are antibodies produced by a single clone of cells consisting of identical antibody molecules. Global Monoclonal Antibodies market continues to gain momentum with the rapid increase in adoption of these products for various indications.
Monoclonal Antibodies have various diagnostic and therapeutic applications, especially in cancer. Apart from these mAb`s are also useful in protein purification. At present, there are forty-seven monoclonal antibody products have been approved in the United States or Europe for the treatment of a wide range of diseases, and many of these products have also been approved in the global markets. At the current approval rate of four new products releasing every year, approximately 70 monoclonal antibody products are expected to be present on the market by 2020.
Global Monoclonal Antibodies market is driven by increasing R & D activities in genomics, owing to rapid advancements of our understanding of disease at a molecular level. The development of new molecules is expected to play a prominent role in the future of the market due to the cost effectiveness of this technology. Rising awareness levels among patients and physicians regarding various applications of mAb is also a major factor fuelling the growth of the market. However huge cost and time associated with the identification and development of potential molecules is a major factor hindering the growth of the market.
The Global market for Monoclonal Antibodies is broadly categorized by Source, Indication, End User and Application. On the basis of source market is segmented into Murine, Chimeric, Humanized and Human. By source Human mAb`s account for the largest share of the market. Based on indication the market is Segmented to cancer, Auto immune diseases, Infectious diseases, Cardiovascular diseases, CNS disorders and others.
Cancer Vaccines are further sub segmented into Blood Cancer, Breast Cancer, Colorectal Cancer, Lung Cancer, Pancreatic Cancer and Others. On the basis of end user, the market is segmented into Hospitals/Clinics, Research Institute and Diagnostic Laboratories. Hospitals is the largest end user segment accounting for a share of approximately XX%. By application global monoclonal antibodies market is segmented into medical and experimental. Based on experimental the market is further sub segmented into Western Blot, ELISA, Radio immune Assays, Immunofluorescence and others.
Market Segmentation: By Source Murine Chimeric Humanized Human
By Indication Cancer -Blood Cancer -Breast Cancer -Colorectal Cancer
Application Medical Experimental
About Market Data Forecast: The publisher of this report Market Data Forecast is well known for the services they render in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering Europe among other regions of the global market as well, that too with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
